About Synteract
Synteract is a company based in Carlsbad (United States) founded in 1986 was acquired by Syneos Health in October 2020. Synteract has raised $3 million across 1 funding round from investors including Syneos Health, Gryphon Investors and Amulet Capital. The company has 378 employees. Synteract has completed 3 acquisitions, including Cu-Tech, Harrison Clinical Research and KinderPharm. Synteract operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
- Headquarter Carlsbad, United States
- Employees 378
- SectorsHealthcare
- Website synteract.com
- Social LinkedIn
- Acquired by Syneos Health (Oct 2020)
- Legal Name Synteract, Inc.
- Total Equity Funding$3M (USD)
in 1 rounds
- Latest Funding Round$3M (USD), Series A
Feb 2014
- InvestorsSyneos Health
& 2 more
- Employee Count378
- Investments & AcquisitionsCu-Tech
& 2 more
- Acquired by
Funding Insights of Synteract
Synteract has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 1
- Last Round Series A — $3M
- First Round $3M
(Feb 2014)
All 1 funding rounds of Synteract with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2014 | $3M | Series A | – | – | – |
3 investors in total: 3 institutional.
Investors in Synteract
Synteract has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Syneos Health, Gryphon Investors and Amulet Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | gryphon-inv.com | - | |
Amulet Capital is focused on healthcare private equity investments. | – | amuletcapital.com | Greenwich, United States | |
CRO clinical development services are provided by Syneos Health. | 1984 | syneoshealth.com | Raleigh, United States |
Investor details for Synteract
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Synteract
10 people are tracked at Synteract (1 in leadership, 9 in team); the tracked headcount is 378.
| Name | Role | Group |
|---|---|---|
Frank Santoro | Chief Medical Officer | Leadership |
Martina Kröner | SVP, Corporate Development | Team |
Teresa Evans | Principal Clinical Research Associate | Team |
Benoit Leclef | Sr Clinical Research Associate | Team |
Florencia Rosignoli | Clinical Operations Manager | Team |
Lori Magnelli | Senior Clinical Trial Manager | Team |
Brenda Grant | Senior Clinical Trial Manager | Team |
Lynette Chan | Senior Manager, Clinical Operations | Team |
Marine Peres | Clinical Team Manager | Team |
Brunella di Meglio | Senior Clinical Research Associate | Team |
Complete people profiles for Synteract
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synteract
Synteract has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cu-Tech, Harrison Clinical Research and KinderPharm.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pediatric CRO services for drug development and formulations are specialized. | kinderpharm.com | Exton, United States | 2014 | Nov 2018 | •••• | |
Full-service dermatology CRO for Phase I-IV clinical trials is operated. | cu-tech.com | New York, United States | 1993 | Jul 2018 | •••• | |
Global full-service CRO with operations in Europe, Israel and the USA (acquired by Synteract in 2013) | harrisonclinical.com | Munich, Germany | 1999 | Mar 2013 | •••• |
Complete acquisition details for Synteract
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Synteract
8 dated milestones of Synteract across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Synteract is founded.
- Exit Acquired by Gryphon Investors.
- Acquisition Acquires Harrison Clinical Research.
- Funding First funding round of $3.0M.
- Exit Acquired by Amulet Capital Partners.
- Acquisition Acquires Cu-Tech.
- Acquisition Acquires KinderPharm.
- Exit Acquired by Syneos Health.
Competitors of Synteract
Synteract operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Emmes and Parexel, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | – | 29,395 | CRO clinical development services are provided by Syneos Health. | |
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. | |
| emmes.com | 1977 | United States | – | 195 | Outsourced contract research organization services are provided to clients. | |
| parexel.com | 1983 | Waltham, United States | – | – | Full-service clinical research organization services are provided globally by Parexel. | |
| prahs.com | 1976 | Raleigh, United States | – | 21 | Global full-service CRO services are delivered in over 80 countries. | |
| veristat.com | 1994 | Southborough, United States | – | 7 | Clinical trials and regulatory submissions are supported as a CRO. | |
| clinchoice.com | 1995 | Fort Washington, United States | $212M | 478 | CRO focused on data management, regulatory affairs and consulting services |
Detailed competitors of Synteract
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synteract
Websites that share an audience with Synteract (synteract.com).
Websites whose visitors overlap most with Synteract. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| emissary.com | 100% | – | – | View details | |
clinuity.com | clinuity.com | 100% | – | – | – |
| quanticate.com | 100% | – | #1,287,633 | View details | |
flcrc.com | flcrc.com | 100% | – | – | – |
| ciscrp.org | 100% | – | #2,147,656 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Synteract
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Synteract
Complete news archive for Synteract
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Synteract
10 companies that operate in the same segment as Synteract (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synteract
Synteract was founded in 1986 and raised its 1st funding round 28 years after it was founded.
Synteract is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Synteract is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on Feb 2014.
Synteract has 378 employees.
In 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research, forming SynteractHCR, an international contract research organisation. SynteractHCR is a global contract research organisation offering CRO services such as project management, clinical operations, medical writing, regulatory affairs and biostatistics etc., for phase I to phase IV research clinical trials. The therapeutic areas covered include oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory. The company claims to have conducted studies in 6 continents covering more than 60 countries. The company SynteractHCR was acquired by Amulet Capital Partners in May 2016.
Synteract's top competitors include Emmes, Syneos Health and ClinChoice.
Synteract has made 3 acquisitions, including Cu-Tech, Harrison Clinical Research, and KinderPharm.
Synteract has 3 investors. Key investors include Syneos Health, Gryphon Investors, and Amulet Capital.
Synteract operates through Synteract, Inc..
Yes. Synteract was acquired by Syneos Health in October 2020.